[1]韩辰燕,刘晓芯,董昀,等.加味香砂六君子汤对食管癌新辅助放化疗患者胃肠道副作用及生活质量的影响[J].西部中医药,2023,36(01):4-7.[doi:10.12174/j.issn.2096-9600.2023.01.02]
　HAN Chenyan,LIU Xiaoxin,DONG Yun,et al.Influence of Modified Xiangsha Liujunzi Tang on Quality of Life and Gastrointestinal Tract Side Effects in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy[J].Western Journal of Traditional Chinese Medicine,2023,36(01):4-7.[doi:10.12174/j.issn.2096-9600.2023.01.02]
点击复制

加味香砂六君子汤对食管癌新辅助放化疗患者胃肠道副作用及生活质量的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年01期
页码:
4-7
栏目:
出版日期:
2023-01-15

文章信息/Info

Title:
Influence of Modified Xiangsha Liujunzi Tang on Quality of Life and Gastrointestinal Tract Side Effects in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
作者:
韩辰燕1,2, 刘晓芯1,2,3, 董昀1,2, 甘婉玲1,2
1.上海市胸科医院，上海 200030
2.上海交通大学医学院附属胸科医院，上海 200030
3.上海交通大学护理学院，上海 200025
Author(s):
HAN Chenyan1,2, LIU Xiaoxin1,2,3, DONG Yun1,2, GAN Wanling1,2
1.Shanghai Chest Hospital, Shanghai 200030, China
2.Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
3.Shanghai JiaoTong University School of Nursing, Shanghai 200025, China
关键词:
食管癌; 胃肠道副作用; 生活质量; 放化疗; 加味香砂六君子汤
Keywords:
esophageal cancer; gastrointestinal tract side effects; quality of life; chemoradiotherapy; modified
分类号:
R243
DOI:
10.12174/j.issn.2096-9600.2023.01.02
文献标志码:
A
摘要:
目的探究加味香砂六君子汤对食管癌新辅助放化疗患者胃肠道副作用及生活质量的影响。 方法将新辅助放化疗食管癌患者138例采用随机数字表法分为试验组与对照组各69例。对照组予常规放化疗护理，试验组在对照组基础上口服加味香砂六君子汤，分别于放化疗3、7、14天根据WHO抗癌药物常见毒副反应分级标准中的便秘、恶心呕吐、腹泻、口腔溃疡分级进行评估。并于放化疗前、放化疗7天及21天对患者生活质量进行评估。 结果便秘及恶心呕吐人数试验组少于对照组，差异有统计学意义（P＜0.05）。试验组患者生活质量在放化疗7天、21天各维度得分均低于对照组，且疼痛、睡眠、身体活动及总分两组比较差异有统计学意义（P＜0.05）。 结论在常规放化疗护理基础上口服加味香砂六君子汤可有效减轻放化疗所致恶心呕吐、便秘症状，提高食管癌患者生活质量。
Abstract:
ObjectiveTo explore the influence of modified Xiangsha Liujunzi Tang on quality of life and gastrointestinal tract side effects in esophageal cancer patients undergoing neoadjuvant chemoradiotherapy. MethodsAll 138 patients were allocated to the experiment group and the control group by using random control method, 69 cases in each group. The control group accepted conventional nursing for chemoradiotherapy, and the experiment group took modified Xiangsha Liujunzi Tang on the foundation of conventional nursing for chemoradiotherapy, to perform the evaluation according to the classification of constipation, nausea and vomiting, diarrhea and oral ulcer in classification criteria for common toxic side effects of anticancer drugs 3, 7 and 14 days after chemoradiotherapy respectively. And to assess quality of life of the patients before chemoradiotherapy, 7 and 21 days after the chemoradiotherapy. ResultsThe number of the patients suffering constipation, nausea and vomiting in the experiment group was less than that of the control group, and the difference was statistically significant (P<0.05). The experiment group was lower than the control group in the dimensional scores of quality of life 7 and 21 days after the chemoradiotherapy; and the difference was statistically significant between both groups in the scores of pain, sleep, physical activity and total scores (P<0.05). ConclusionOn the foundation of conventional nursing for chemoradiotherapy, oral administration of modified Xiangsha Liujunzi Tang could effectively alleviate nausea and vomiting, constipation induced by chemotherapy, and improve quality of life in esophageal cancer patients.

相似文献/References:

[1]吴茂林,李世杰,指导：段俊国.半夏泻心汤加味治疗晚期食管癌临床疗效评价[J].西部中医药,2015,28(05):50.
[2]付彦俐.淮河流域早期食管癌内镜碘染色普查与中医证型关系的研究[J].西部中医药,2013,26(05):62.
　FU Yanli.Study on the Relationship between Patterns and Endoscopic Iodine Staining in the Investigation of Early Esophageal Cancer around Huaihe River Basin[J].Western Journal of Traditional Chinese Medicine,2013,26(01):62.
[3]张艳霞,周俊娣△.食管癌术后并发乳糜胸的护理干预[J].西部中医药,2013,26(10):125.
　ZHANG Yanxia,ZHOU Jundi.Nursing Intervention for Postoperative Patients Suffering from Esophageal Cancer Complicated with Chylopleura[J].Western Journal of Traditional Chinese Medicine,2013,26(01):125.
[4]祁元刚,李彦霞.裴正学教授治疗食管癌临床经验[J].西部中医药,2016,29(04):46.
　QI Yuangang,LI Yanxia.Professor Pei Zhengxue′s Clinical Experience of Treating Esophageal Cancer[J].Western Journal of Traditional Chinese Medicine,2016,29(01):46.
[5]刘明,党建中.中西医结合治疗食管癌切除术后吻合口瘘疗效观察[J].西部中医药,2018,31(03):102.
　LIU Ming,DANG Jianzhong.Observation on Clinical Effects of Integrative Medicine in Treating Anastomotic Leakage after the Excision of Esophageal Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(01):102.
[6]赵玮,徐力.徐力教授运用“三段六辨”治疗食管癌经验[J].西部中医药,2020,33(05):42.[doi:10.12174/j.issn.1004-6852.2020.05.12]
　ZHAO Wei,XU Li.Professor Xu Li′s Experience of Treating Esophageal Cancer by ″Three Stages and Six Differentiations″[J].Western Journal of Traditional Chinese Medicine,2020,33(01):42.[doi:10.12174/j.issn.1004-6852.2020.05.12]

备注/Memo

备注/Memo:
韩辰燕（1988—），女，硕士学位，主管护师。研究方向：护理管理与肿瘤护理学。国家自然科学基金青年基金（81904114）；上海市加强公共卫生体系建设三年行动计划（2020—2022）项目（GWV-5）；上海交通大学医学院护理科研项目（Jyhz2037）。
更新日期/Last Update: 2023-01-15